Related Experiment Videos
Plasma exchange and leukapheresis in psoriasis--no effect?
Archives of Dermatological Research
|January 1, 1986
Summary
Plasma exchange and leukapheresis did not improve severe psoriasis in nine patients. These findings suggest that removing a "psoriasis factor" or leukocytes does not effectively treat this skin condition.
Area of Science:
- Dermatology
- Immunology
- Medical Technology
Background:
- Psoriasis is a chronic inflammatory skin disease.
- Dialysis has shown some beneficial effects in psoriasis patients, suggesting a potential
- psoriasis factor
- or circulating toxins.
Purpose of the Study:
- To investigate the efficacy of plasma exchange and leukapheresis in treating severe or therapy-resistant psoriasis.
- To evaluate the hypothesis that a removable
- psoriasis factor
- contributes to the disease.
- To determine if reducing leukocyte counts impacts psoriasis severity.
Main Methods:
- Nine patients with severe or therapy-resistant psoriasis were enrolled.
- Treatments included plasma exchange and/or leukapheresis.
- Patients were monitored for clinical improvement.
Main Results:
- None of the nine patients exhibited convincing signs of improvement after treatment.
- No significant reduction in psoriasis severity was observed.
- The study found no evidence supporting the
- psoriasis factor
- hypothesis.
Conclusions:
- Plasma exchange and leukapheresis are not effective treatments for severe or therapy-resistant psoriasis.
- The results challenge the existence of a removable
- psoriasis factor
- as a primary driver of psoriasis.
- Removing large numbers of leukocytes does not appear to promote healing in psoriasis patients.